162 related articles for article (PubMed ID: 24810336)
1. miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma.
Minna E; Romeo P; De Cecco L; Dugo M; Cassinelli G; Pilotti S; Degl'Innocenti D; Lanzi C; Casalini P; Pierotti MA; Greco A; Borrello MG
Oncotarget; 2014 May; 5(9):2513-28. PubMed ID: 24810336
[TBL] [Abstract][Full Text] [Related]
2. PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration.
Chiappetta G; Valentino T; Vitiello M; Pasquinelli R; Monaco M; Palma G; Sepe R; Luciano A; Pallante P; Palmieri D; Aiello C; Rea D; Losito SN; Arra C; Fusco A; Fedele M
Oncotarget; 2015 Mar; 6(7):5310-23. PubMed ID: 25595894
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
Mitomo S; Maesawa C; Ogasawara S; Iwaya T; Shibazaki M; Yashima-Abo A; Kotani K; Oikawa H; Sakurai E; Izutsu N; Kato K; Komatsu H; Ikeda K; Wakabayashi G; Masuda T
Cancer Sci; 2008 Feb; 99(2):280-6. PubMed ID: 18201269
[TBL] [Abstract][Full Text] [Related]
4. MiR-203a-3p, miR-204-3p, miR-222-3p as useful diagnostic and prognostic tool for thyroid neoplasia spectrum.
Stojanović S; Dobrijević Z; Šelemetjev S; Đorić I; Janković Miljuš J; Živaljević V; Išić Denčić T
Endocrine; 2023 Jan; 79(1):98-112. PubMed ID: 36103016
[TBL] [Abstract][Full Text] [Related]
5. Plasma exosomal miR-199a-3p downregulates cell proliferation and migration in Hirschsprung's disease by targeting mTOR.
Daiyue Y; Yang Y; Zhaorong H; Yi L; Chen W; Caiyun L; Yuqian S; Liucheng Y; Kai W
Pediatr Surg Int; 2022 Dec; 39(1):54. PubMed ID: 36534156
[TBL] [Abstract][Full Text] [Related]
6. miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.
Xiong Y; Kotian S; Zeiger MA; Zhang L; Kebebew E
PLoS One; 2015; 10(8):e0130496. PubMed ID: 26244545
[TBL] [Abstract][Full Text] [Related]
7. Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use.
Michailidi C; Hayashi M; Datta S; Sen T; Zenner K; Oladeru O; Brait M; Izumchenko E; Baras A; VandenBussche C; Argos M; Bivalacqua TJ; Ahsan H; Hahn NM; Netto GJ; Sidransky D; Hoque MO
Cancer Prev Res (Phila); 2015 Mar; 8(3):208-21. PubMed ID: 25586904
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.
Takakura S; Mitsutake N; Nakashima M; Namba H; Saenko VA; Rogounovitch TI; Nakazawa Y; Hayashi T; Ohtsuru A; Yamashita S
Cancer Sci; 2008 Jun; 99(6):1147-54. PubMed ID: 18429962
[TBL] [Abstract][Full Text] [Related]
9. HHV-6A Infection of Papillary Thyroid Cancer Cells Induces Several Effects Related to Cancer Progression.
Mardente S; Romeo MA; Asquino A; Po A; Gilardini Montani MS; Cirone M
Viruses; 2023 Oct; 15(10):. PubMed ID: 37896899
[TBL] [Abstract][Full Text] [Related]
10. DLK1-DIO3 region as a source of tumor suppressor miRNAs in papillary thyroid carcinoma.
Alves LF; Marson LA; Sielski MS; Vicente CP; Kimura ET; Geraldo MV
Transl Oncol; 2024 May; 46():101849. PubMed ID: 38823258
[TBL] [Abstract][Full Text] [Related]
11. MiR-20b Tissue Expression Level Displays the Diagnostic Value in Papillary Thyroid Carcinoma.
Honardoost M; Maghsoomi Z; Karimi Behnagh A; Hosseinkhan N; Abdolmaleki F; Panahi M; E Khamseh M
Med J Islam Repub Iran; 2023; 37():101. PubMed ID: 38021380
[TBL] [Abstract][Full Text] [Related]
12. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
[TBL] [Abstract][Full Text] [Related]
13. miR-199a-3p negatively regulates the progression of osteosarcoma through targeting AXL.
Tian R; Xie X; Han J; Luo C; Yong B; Peng H; Shen J; Peng T
Am J Cancer Res; 2014; 4(6):738-50. PubMed ID: 25520864
[TBL] [Abstract][Full Text] [Related]
14. MiR-199a-3p promotes gastric cancer progression by targeting ZHX1.
Wang Z; Ma X; Cai Q; Wang X; Yu B; Cai Q; liu B; Zhu Z; Li C
FEBS Lett; 2014 Nov; 588(23):4504-12. PubMed ID: 25448600
[TBL] [Abstract][Full Text] [Related]
15. MiR-199a regulates cell proliferation and survival by targeting FZD7.
Song J; Gao L; Yang G; Tang S; Xie H; Wang Y; Wang J; Zhang Y; Jin J; Gou Y; Yang Z; Chen Z; Wu K; Liu J; Fan D
PLoS One; 2014; 9(10):e110074. PubMed ID: 25313882
[TBL] [Abstract][Full Text] [Related]
16. Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.
Peng Y; Li C; Luo DC; Ding JW; Zhang W; Pan G
Molecules; 2014 Aug; 19(8):11586-99. PubMed ID: 25100252
[TBL] [Abstract][Full Text] [Related]
17. Non-coding RNA-mediated epigenetic alterations in Grave's ophthalmopathy: A scoping systematic review.
Shahraki K; Pak VI; Najafi A; Shahraki K; Boroumand PG; Sheervalilou R
Noncoding RNA Res; 2023 Sep; 8(3):426-450. PubMed ID: 37324526
[TBL] [Abstract][Full Text] [Related]
18. Circ_0003747 promotes thyroid cancer progression by sponging miR-338-3p to upregulate PLCD3 expression.
Dou XL; Xia FD; Li XY
Epigenetics; 2023 Dec; 18(1):2210339. PubMed ID: 37166441
[TBL] [Abstract][Full Text] [Related]
19. The Potential of Novel Lipid Agents for the Treatment of Chemotherapy-Resistant Human Epithelial Ovarian Cancer.
Nachtigal MW; Altman AD; Arora R; Schweizer F; Arthur G
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884379
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-199a-3p promotes drug sensitivity in triple negative breast cancer by down-regulation of
Ho JC; Chen J; Cheuk IW; Siu MT; Shin VY; Kwong A
Am J Transl Res; 2022; 14(3):2021-2036. PubMed ID: 35422914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
